{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:11:34Z","timestamp":1794971494483,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58657-x","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:03:35Z","timestamp":1745298215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Model-based evaluation of the impact of a potential HIV cure on HIV transmission dynamics"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8903-5685","authenticated-orcid":false,"given":"Alfredo","family":"De Bellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-1941","authenticated-orcid":false,"given":"Myrthe S.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-9470","authenticated-orcid":false,"given":"Giorgio","family":"Guzzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6656-0516","authenticated-orcid":false,"given":"Ard","family":"van Sighem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-3826","authenticated-orcid":false,"given":"Kim A. G. J.","family":"Romijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7896-6428","authenticated-orcid":false,"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-7002","authenticated-orcid":false,"given":"Maarten F.","family":"Schim van der Loeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2728-4560","authenticated-orcid":false,"given":"Janneke H. H. M.","family":"van de Wijgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6610-8282","authenticated-orcid":false,"given":"Monique","family":"Nijhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4394-7697","authenticated-orcid":false,"given":"Mirjam E. E.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-7359","authenticated-orcid":false,"given":"Ganna","family":"Rozhnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"58657_CR1","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS). Understanding fast-track accelerating action to end the AIDS epidemic by 2030 https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/201506_JC2743_Understanding_FastTrack_en.pdf (2015)."},{"key":"58657_CR2","unstructured":"van Sighem, A. et al. Monitoring Report 2023. Human Immunodeficiency Virus (HIV) infection in the Netherlands. Amsterdam: Stichting HIV monitoring https:\/\/www.hiv-monitoring.nl (2023)."},{"key":"58657_CR3","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1016\/S2352-3018(21)00044-8","volume":"8","author":"F Brizzi","year":"2021","unstructured":"Brizzi, F. et al. Tracking elimination of HIV transmission in men who have sex with men in England: a modelling study. Lancet HIV 8, e440\u2013e448 (2021).","journal-title":"Lancet HIV"},{"key":"58657_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33570-0","volume":"8","author":"L Palk","year":"2018","unstructured":"Palk, L., Gerstoft, J., Obel, N. & Blower, S. A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination. Sci. Rep. 8, 16003 (2018).","journal-title":"Sci. Rep."},{"key":"58657_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack, S. et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 387, 53\u201360 (2016).","journal-title":"Lancet"},{"key":"58657_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen, M. S. et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med 365, 493\u2013505 (2011).","journal-title":"N. Engl. J. Med"},{"key":"58657_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-019-1841-8","volume":"576","author":"T Ndung\u2019u","year":"2019","unstructured":"Ndung\u2019u, T., McCune, J. M. & Deeks, S. G. Why and where an HIV cure is needed and how it might be achieved. Nature 576, 397\u2013405 (2019).","journal-title":"Nature"},{"key":"58657_CR8","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S2352-3018(20)30232-0","volume":"8","author":"M Dybul","year":"2021","unstructured":"Dybul, M. et al. The case for an HIV cure and how to get there. Lancet HIV 8, e51\u2013e58 (2021).","journal-title":"Lancet HIV"},{"key":"58657_CR9","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2352-3018(20)30234-4","volume":"8","author":"SR Lewin","year":"2021","unstructured":"Lewin, S. R. et al. Multi-stakeholder consensus on a target product profile for an HIV cure. Lancet HIV 8, e42\u2013e50 (2021).","journal-title":"Lancet HIV"},{"key":"58657_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/QAD.0000000000001511","volume":"31","author":"N Langebeek","year":"2017","unstructured":"Langebeek, N. et al. Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals. AIDS 31, 1471\u20131481 (2017).","journal-title":"AIDS"},{"key":"58657_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/09540121.2018.1545990","volume":"31","author":"G Zeluf-Andersson","year":"2019","unstructured":"Zeluf-Andersson, G. et al. Beyond viral suppression: the quality of life of people living with HIV in Sweden. AIDS Care 31, 403\u2013412 (2019).","journal-title":"AIDS Care"},{"key":"58657_CR12","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1016\/S2352-3018(20)30197-1","volume":"7","author":"WPH van Bilsen","year":"2020","unstructured":"van Bilsen, W. P. H., Zimmermann, H. M. L., Boyd, A. & Davidovich, U. Burden of living with HIV among men who have sex with men: a mixed-methods study. Lancet HIV 7, e835\u2013e843 (2020).","journal-title":"Lancet HIV"},{"key":"58657_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10461-020-03055-1","volume":"25","author":"P de los Rios","year":"2021","unstructured":"de los Rios, P. et al. Physical, emotional, and psychosocial challenges associated with daily dosing of HIV medications and their impact on indicators of quality of life: findings from the positive perspectives study. AIDS Behav 25, 961\u2013972 (2021).","journal-title":"AIDS Behav"},{"key":"58657_CR14","doi-asserted-by":"publisher","first-page":"100066","DOI":"10.1016\/j.jve.2022.100066","volume":"8","author":"KA Romijnders","year":"2022","unstructured":"Romijnders, K. A. et al. The perceived impact of an HIV cure by people living with HIV and key populations vulnerable to HIV in the Netherlands: a qualitative study. J. Virus Erad. 8, 100066 (2022).","journal-title":"J. Virus Erad."},{"key":"58657_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25113-5","volume":"12","author":"KAGJ Romijnders","year":"2022","unstructured":"Romijnders, K. A. G. J. et al. The experienced positive and negative influence of HIV on quality of life of people with HIV and vulnerable to HIV in the Netherlands. Sci. Rep. 12, 21887 (2022).","journal-title":"Sci. Rep."},{"key":"58657_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/14787210.2023.2273919","volume":"21","author":"MD Schou","year":"2023","unstructured":"Schou, M. D., S\u00f8gaard, O. S. & Rasmussen, T. A. Clinical trials aimed at HIV cure or remission: new pathways and lessons learned. Expert Rev. Anti-infective Ther 21, 1227\u20131243 (2023).","journal-title":"Expert Rev. Anti-infective Ther"},{"key":"58657_CR17","unstructured":"Treatment Action Group. Research toward a cure trials www.treatmentactiongroup.org\/cure\/trials (2024)."},{"key":"58657_CR18","doi-asserted-by":"publisher","first-page":"109741","DOI":"10.1016\/j.clim.2023.109741","volume":"255","author":"A Khan","year":"2023","unstructured":"Khan, A., Paneerselvam, N. & Lawson, B. R. Antiretrovirals to CCR5 CRISPR\/Cas9 gene editing-A paradigm shift chasing an HIV cure. Clin. Immunol. 255, 109741 (2023).","journal-title":"Clin. Immunol."},{"key":"58657_CR19","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks, S. G. et al. Research priorities for an HIV cure: International AIDS society global scientific strategy 2021. Nat. Med. 27, 2085\u20132098 (2021).","journal-title":"Nat. Med"},{"key":"58657_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0229733","volume":"15","author":"J Power","year":"2020","unstructured":"Power, J. et al. The significance and expectations of HIV cure research among people living with HIV in Australia. PLoS One 15, 1\u201315 (2020).","journal-title":"PLoS One"},{"key":"58657_CR21","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/S2352-3018(18)30039-0","volume":"5","author":"MC Pitman","year":"2018","unstructured":"Pitman, M. C., Lau, J. S. Y., McMahon, J. H. & Lewin, S. R. Barriers and strategies to achieve a cure for HIV. Lancet HIV 5, e317\u2013e328 (2018).","journal-title":"Lancet HIV"},{"key":"58657_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/v12010084","volume":"12","author":"G Vansant","year":"2020","unstructured":"Vansant, G., Bruggemans, A., Janssens, J. & Debyser, Z. Block-and-lock strategies to cure HIV infection. Viruses 12, 84 (2020).","journal-title":"Viruses"},{"key":"58657_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40265-020-01322-y","volume":"80","author":"L Bailon","year":"2020","unstructured":"Bailon, L., Mothe, B., Berman, L. & Brander, C. Novel approaches towards a functional cure of HIV\/AIDS. Drugs 80, 859\u2013868 (2020).","journal-title":"Drugs"},{"key":"58657_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41579-023-00914-1","volume":"21","author":"RJ Landovitz","year":"2023","unstructured":"Landovitz, R. J., Scott, H. & Deeks, S. G. Prevention, treatment and cure of HIV infection. Nat. Rev. Microbiol. 21, 657\u2013670 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"58657_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/sti.78.1.7","volume":"78","author":"GP Garnett","year":"2002","unstructured":"Garnett, G. P. An introduction to mathematical models in sexually transmitted disease epidemiology. Sex. Transm. Infect. 78, 7\u201312 (2002).","journal-title":"Sex. Transm. Infect."},{"key":"58657_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40273-023-01260-z","volume":"41","author":"R Giddings","year":"2023","unstructured":"Giddings, R. et al. Infectious disease modelling of HIV prevention interventions: a systematic review and narrative synthesis of compartmental models. PharmacoEconomics 41, 693\u2013707 (2023).","journal-title":"PharmacoEconomics"},{"key":"58657_CR27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/QAD.0000000000000115","volume":"28","author":"TB Hallett","year":"2014","unstructured":"Hallett, T. B. et al. Using modeling to inform international guidelines for antiretroviral treatment. AIDS 28, S1\u2013S4 (2014).","journal-title":"AIDS"},{"key":"58657_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","volume":"373","author":"RM Granich","year":"2008","unstructured":"Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M. & Williams, B. G. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373, 48\u201357 (2008).","journal-title":"Lancet"},{"key":"58657_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep22183","volume":"6","author":"DT Dimitrov","year":"2016","unstructured":"Dimitrov, D. T., Kiem, H.-P., Jerome, K. R., Johnston, C. & Schiffer, J. T. A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-na\u00edve population. Sci. Rep. 6, 22183 (2016).","journal-title":"Sci. Rep."},{"key":"58657_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41256-019-0107-1","volume":"4","author":"L Beacroft","year":"2019","unstructured":"Beacroft, L. & Hallett, T. B. The potential impact of a \u201ccurative intervention\u201d for HIV: a modelling study. Glob. Health Res. Policy 4, 1\u20138 (2019).","journal-title":"Glob. Health Res. Policy"},{"key":"58657_CR31","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS Key Population Atlas https:\/\/kpatlas.unaids.org\/dashboard (2024)."},{"key":"58657_CR32","unstructured":"Nederlandse multidisciplinaire richtlijn. Pre-expositie profylaxe (PrEP) ter preventie van HIV (2022). https:\/\/www.soaaids.nl\/files\/2022-07\/20220711-PrEP-richtlijn-Nederland-versie-3-update-2022.pdf. Accessed August 18, 2024."},{"key":"58657_CR33","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/cid\/ciz417","volume":"70","author":"M Stecher","year":"2020","unstructured":"Stecher, M. et al. Systematic review and meta-analysis of treatment interruptions in human immunodeficiency virus (HIV) type 1\u2013infected patients receiving antiretroviral therapy: implications for future HIV cure trials. Clin. Infect. Dis. 70, 1406\u20131417 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"58657_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2055-6640(20)30929-8","volume":"1","author":"KA Freedberg","year":"2015","unstructured":"Freedberg, K. A. et al. The HIV cure research agenda: the role of mathematical modelling and costeffectiveness analysis. J. Virus Erad. 1, 245\u2013249 (2015).","journal-title":"J. Virus Erad."},{"key":"58657_CR35","unstructured":"Noorman, M. A. J. et al. Towards inclusive HIV cure development: Identifying important and acceptable HIV cure attributes and strategies among people with HIV in The Netherlands. Submitted (2025)."},{"key":"58657_CR36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/cid\/ciaa645","volume":"73","author":"AM Newsum","year":"2020","unstructured":"Newsum, A. M. et al. Incidence of HCV reinfection among HIV-positive MSM and its association with sexual risk behavior: a longitudinal analysis. Clin. Infect. Dis. 73, 460\u2013467 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"58657_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/QAI.0000000000003511","volume":"97","author":"M Reitsema","year":"2024","unstructured":"Reitsema, M. et al. Impact of varying pre-exposure prophylaxis programs on HIV and Neisseria gonorrhoeae transmission among MSM in the Netherlands: a modeling study. JAIDS J. Acquired Immune Defic. Syndromes 97, 325\u2013333 (2024).","journal-title":"JAIDS J. Acquired Immune Defic. Syndromes"},{"key":"58657_CR38","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1097\/QAD.0000000000002050","volume":"32","author":"G Rozhnova","year":"2018","unstructured":"Rozhnova, G. et al. Elimination prospects of the dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis. AIDS 32, 2615\u20132623 (2018).","journal-title":"AIDS"},{"key":"58657_CR39","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1473-3099(16)30311-5","volume":"16","author":"BE Nichols","year":"2016","unstructured":"Nichols, B. E., Boucher, C. A., van der Valk, M., Rijnders, B. J. & van de Vijver, D. A. Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study. Lancet Infect. Dis. 16, 1423\u20131429 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"58657_CR40","doi-asserted-by":"crossref","unstructured":"Jansen, I. A. et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 25, 493-501 (2011).","DOI":"10.1097\/QAD.0b013e328342fbe9"},{"key":"58657_CR41","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/QAD.0b013e3281532c82","volume":"21","author":"CD Pilcher","year":"2007","unstructured":"Pilcher, C. D. et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 21, 1723\u20131730 (2007).","journal-title":"AIDS"},{"key":"58657_CR42","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/jac\/dkz138","volume":"74","author":"A Castagna","year":"2019","unstructured":"Castagna, A. et al. Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study). J. Antimicrobial Chemother 74, 2039\u20132046 (2019).","journal-title":"J. Antimicrobial Chemother"},{"key":"58657_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-4-67","volume":"4","author":"AC van der Kuyl","year":"2007","unstructured":"van der Kuyl, A. C. & Cornelissen, M. Identifying HIV-1 dual infections. Retrovirology 4, 1\u201312 (2007).","journal-title":"Retrovirology"},{"key":"58657_CR44","doi-asserted-by":"crossref","unstructured":"Lambers, F. A. et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 25, (2011).","DOI":"10.1097\/QAD.0b013e32834bac44"},{"key":"58657_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/COH.0b013e32835ea1c5","volume":"8","author":"B Lo","year":"2013","unstructured":"Lo, B., Grady, C. & on Ethics of the International AIDS Society, W. G. et al. Ethical considerations in HIV cure research: points to consider. Curr. Opin. HIV AIDS 8, 243\u2013249 (2013).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"58657_CR46","doi-asserted-by":"publisher","first-page":"e1002470","DOI":"10.1371\/journal.pmed.1002470","volume":"14","author":"K Dub\u00e9","year":"2017","unstructured":"Dub\u00e9, K. et al. Research on HIV cure: mapping the ethics landscape. PLoS Med 14, e1002470 (2017).","journal-title":"PLoS Med"},{"key":"58657_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12910-021-00651-1","volume":"22","author":"K Dub\u00e9","year":"2021","unstructured":"Dub\u00e9, K. et al. Ethics of HIV cure research: an unfinished agenda. BMC Med. Ethics 22, 1\u201314 (2021).","journal-title":"BMC Med. Ethics"},{"key":"58657_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.tim.2015.10.011","volume":"24","author":"CI Grossman","year":"2016","unstructured":"Grossman, C. I. et al. Towards multidisciplinary HIV-cure research: integrating social science with biomedical research. Trends Microbiol 24, 5\u201311 (2016).","journal-title":"Trends Microbiol"},{"key":"58657_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-021-00565-1","volume":"18","author":"SD Ismail","year":"2021","unstructured":"Ismail, S. D. et al. Addressing an HIV cure in LMIC. Retrovirology 18, 21 (2021).","journal-title":"Retrovirology"},{"key":"58657_CR50","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/cid\/ciaa505","volume":"72","author":"M Dijkstra","year":"2021","unstructured":"Dijkstra, M. et al. Decreased time to viral suppression after implementation of targeted testing and immediate initiation of treatment of acute human immunodeficiency virus infection among men who have sex with men in Amsterdam. Clin. Infect. Dis. 72, 1952\u20131960 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"58657_CR51","doi-asserted-by":"publisher","unstructured":"Romijnders, K. et al. The expected impact of HIV post-treatment control and HIV elimination on quality of life, sexual satisfaction, and stigma among people with HIV and key populations. Accepted for publication in Communications Medicine. https:\/\/doi.org\/10.21203\/rs.3.rs-4311908\/v1 (2024).","DOI":"10.21203\/rs.3.rs-4311908\/v1"},{"key":"58657_CR52","doi-asserted-by":"crossref","unstructured":"Boender, T. S. et al. AIDS therapy evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile. BMJ Open 8, e022516 (2018).","DOI":"10.1136\/bmjopen-2018-022516"},{"key":"58657_CR53","unstructured":"ECDC HIV Platform tool [Software Application]. Version 3.0.3 stockholm: European centre for disease prevention and control https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hiv-platform-tool (2021)."},{"key":"58657_CR54","unstructured":"Kayaert, L. et al. Sexually transmitted infections in the Netherlands 2022. Bilthoven: National Institute for Public Health and the Environment, RIVM https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2023-0161.pdf (2023)."},{"key":"58657_CR55","doi-asserted-by":"publisher","first-page":"e1005012","DOI":"10.1371\/journal.pcbi.1005012","volume":"12","author":"G Rozhnova","year":"2016","unstructured":"Rozhnova, G., van der Loeff, M. F. S., Heijne, J. C. M. & Kretzschmar, M. E. Impact of heterogeneity in sexual behavior on effectiveness in reducing HIV transmission with test-and-treat strategy. PLoS Comput. Biol. 12, e1005012 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"58657_CR56","doi-asserted-by":"publisher","unstructured":"De Bellis, A. et al. Model-based evaluation of the impact of a potential HIV cure on HIV transmission dynamics. hivcure_rev v1.0.0 - public release https:\/\/doi.org\/10.5281\/zenodo.15031608 (2025).","DOI":"10.5281\/zenodo.15031608"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58657-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58657-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58657-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:03:46Z","timestamp":1745298226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58657-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58657"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58657-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.20.24317612","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.v.S. reports grants, paid to his institution, from the Dutch Ministry of Health, Welfare and Sport through the Centre for Infectious Disease Control of the National Institute for Public Health and the Environment, and from the European Centre for Disease Prevention and Control (ECDC). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3527"}}